An overview of depot buprenorphine

2:00pm Thursday, 29 October 2020
3:00pm Thursday, 29 October 2020
Webinar

This webinar will cover the following learning objectives: 

  • Outline the role of buprenorphine depots in the treatment of opioid dependence
  • Compare the pharmacokinetic profiles, evidence for use, adverse effects, and patient experiences of buprenorphine depot formulations
  • Identify key considerations for buprenorphine depot use and management in a hospital setting and special patient populations
  • Describe the process and dosing considerations of transferring a patient from sublingual to depot buprenorphine
  • Overview studies examining buprenorphine depots, including the DEBUT and UNLOC-T studies
  • Review case examples of buprenorphine depot use in practice

This webinar will commence at 2:00pm AEDT

Registration rates:

Member: Free
Non-member: $50

  • Register in the purple box below, then click on 'cart' at the top of the page (or under your menu options) and continue through checkout.
  • Still having trouble registering? Follow our handy ‘how to’ guide
  • Click here to view our Terms and Conditions

 

* You will receive a confirmation email upon completion of your registration. If you do not receive this within 4 hours, you have not completed your registration and your space is not guaranteed. Please contact the secretariat by emailing events@shpa.org.au.

Sold Out

Contact Information

Additional Information

Presenter

  • Dr Adrian Dunlop, Director & Senior Staff Specialist, Drug & Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW; Conjoint Professor, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, NSW; President-Elect, Chapter of Addiction Medicine, Royal Australian College of Physicians, Melbourne, Vic

Competency standards*

  • Standard 3.1.2 Assess medication management practices and needs
  • Standard 3.2.3 Dispense medicines (including compounded medicines) in consultation with the patient and/or prescriber
  • Standard 3.3.1 Undertake a clinical review

*National competency standards framework for pharmacists in Australia, 2016

Accreditation

This activity has been accredited for 1 hour of Group 1 CPD (or 1 CPD credit), suitable for inclusion in an individual pharmacist's CPD plan. The accreditation number is S2020/57.

APC logo